Area: Cardiology
Location: Barcelona, Spain
Date: August 30 to September 3
Description:
European Society of Cardiology Congress
The COPPS-2 randomized clinical trial
NECTAR-HF trial
PARADIGM-HF trial
CONFIRM-HF trial
MORE-CRT Trial primary results
POPE and POPE-2 study
A batteryless cardiac pacemaker powered
Real-world multicenter prospective registry using DFM TAVI for the treatment of severe aortic stenosis: comparison with the DISCOVER Trial
Local versus general anesthesia in patients undergoing TAVI using an transfemoral approach: Results from the FRANCE 2 registry
The stabilization of pLaques using Darapladib (SOLID)-TIMI 52 trial: Primary results
Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated daily statin: results from the ODYSSEY COMBO II study
Results of ODYSSEY FH I and FH II studies
Long term safety, tolerability and efficacy of alirocumab versus placebo in high cardiovascular risk patients: first results from the ODYSSEY LONG TERM study in 2341 patients
Randomised comparison of a novel, ultrathin strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolumus-eluting stent for percutaneous coronary revascularization
The ANTHEM-HF study
BIOPACE trial preliminary results